Business · 21/01/2020Updated: 10/17/2026 · 1 min read
FDA to Host Public Meeting on Rare Disease Product Development
Summary
The Food and Drug Administration is hosting a public meeting to gather stakeholders' perspectives on challenges and solutions in rare disease product development, with a focus on supporting the future of rare disease product development.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →